Glycomine
Updated: March 08, 2026
CEO - Steven Axon
Country: USA | Funding: $195M (+)
Founded: 2013
Website: https://www.glycomine.com/
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Founded: 2013
Website: https://www.glycomine.com/
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
